1. Israel Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Elbit Imaging Ltd.

Elbit Imaging Ltd.

EMITF
Elbit Imaging Ltd.US flagOther OTC
1.60
USD
- -
- -
21.25MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.74
50.35
25.27
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.06
28.49
Basic EPS, GAAP
-2,784.91
127.46
-23.51
-21.2
-36.78
-56.34
-11.7
25.01
-2.24
-0.26
-0.27
-0.5
-0.43
-21.2
Free Cash Flow per Basic Share
33.51
34.94
21.18
8.07
46.75
-2.21
-1.61
-1.7
-0.37
-0.04
-0.04
-0.05
0.54
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
0.27
1.11
0.14
- -
- -
- -
Book Value per Share
-384.61
124.8
111.32
76.08
73.51
17.45
5.79
30.8
28.35
27.53
-0.89
5.43
5.45
76.08
Tangible Book Value per Share
-2,488.49
29.31
38.4
5.29
-16.19
-6.54
-18.41
10.28
7.74
6.92
-0.07
6.42
7.06
5.29
Basic Weighted Avg Shares
- -
8
8
9
9
9
9
9
9
9
10
11
12
9
Sales/Revenue/Turnover
2
399
200
- -
- -
- -
- -
- -
- -
- -
- -
- -
38
262
Operating Margin (%)
-2,900.71
-26.84
-53.46
- -
- -
- -
- -
- -
- -
- -
- -
- -
-6.29
-9
Depreciation Expense
4
583
123
196
120
113
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1,156
1,009
-186
-195
-338
-518
-107
230
-20
-2
-3
-5
-5
-195
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-58,811.45
253.15
-93.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
-14.03
-74.4
Working Capital
-2,694
102
-589
-1,031
-363
-110
-108
-3
21
35
- -
68
-18
-1,031
LT Debt
- -
756
1,444
853
243
145
159
- -
- -
- -
2
2
71
853
Total Equity
-1,033
232
304
49
-149
-60
-169
94
71
63
-1
68
87
49
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-19.92
-24.65
-49.17
-123.88
-100.66
136.71
-7.55
-0.93
-7.47
- -
-8.47
-24.65

Capital Structure

FRC

•

in mil. unless spec.
Jun'16
Sep'16
Dec'16
ST Debt
507
437
1,129
LT Borrowings
1,672
1,683
853
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jun'16
Sep'16
Dec'16
Total Current Assets
314
250
179
Cash, Cash Equivalents & STI
187
194
94
Accounts Receivable, Net
14
41
34
Inventories
2
2
2
Total Current Liabilities
595
526
1,210
Payables & Accruals
87
89
52
ST Debt
507
437
1,129
Deferred Revenue
- -
- -
6

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1,055.57%
-2,006.34%
27.1%
Free Cash Flow
- -
- -
-1,244.16%
Net Income, GAAP
-34.59%
-16.83%
-0.71%
Sales/Revenue/Turnover
- -
- -
-81.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
24
14
- -
38

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.27
2024
- -
-0.06
- -
- -
-0.5
2025
- -
-0.15
- -
- -
-0.43

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.14
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Eran Mazor
Full Time Employees
3
Sector
Healthcare
Industry
Medical - Devices
Address
3 Shimson Street Petah Tikva Israel 4900102
IPO Date
Nov 27, 1996
CIK
0001027662
Website
elbitimaging.com
Similar Companies
Olympus Corporation (OCPNF)
Health Logic Interactive Inc. (CHYPF)
Aurora Spine Corporation (ASG.V)
Quotient Limited (QTNT)
ThermoGenesis Holdings, Inc. (THMO)
ResMed Inc. (RMD)
Business
Elbit Imaging Ltd. operates as an Israeli holding entity with a diversified portfolio spanning real estate and advanced medical industries. Through its various subsidiaries, the company is actively engaged in the research, development, production, and global distribution of sophisticated therapeutic medical systems. These innovative solutions leverage magnetic resonance imaging (MRI)-guided focused ultrasound technology for non-invasive treatments across the human body. Furthermore, its medical industry interests include the advancement of stem cell population expansion technologies and the creation of stem cell therapy products, intended for transplantation and regenerative medicine to address various conditions such as certain types of cancer and blood disorders. The geographical reach for its medical systems extends across North and South America, Europe, Asia, and Oceania. Concurrently, the company maintains substantial involvement in real estate, encompassing the initiation, construction, and sale of commercial centers, hotel operations, and residential developments. These property ventures are primarily concentrated in Central and Eastern Europe and India, with a focus on plots designated for residential projects. Founded in 1996, Elbit Imaging Ltd. is headquartered in Petach Tikva, Israel.